Fas-Independent Fashion Cells in a MHC Antigen-and Immunoreceptor Efficiently Lyse Target T Cells Engrafted with a Recombinant + CD 4 Hinrich

[1]  V. Diehl,et al.  An entirely humanized CD3 ζ‐chain signaling receptor that directs peripheral blood t cells to specific lysis of carcinoembryonic antigen–positive tumor cells , 2000, International journal of cancer.

[2]  R. Korngold,et al.  Differential use of FasL- and perforin-mediated cytolytic mechanisms by T-cell subsets involved in graft-versus-myeloid leukemia responses. , 2000, Blood.

[3]  J. Trapani,et al.  Redirected Perforin-Dependent Lysis of Colon Carcinoma by Ex Vivo Genetically Engineered CTL1 , 2000, The Journal of Immunology.

[4]  S. Fujita,et al.  Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans. , 2000, Blood.

[5]  V. Diehl,et al.  T cell activation by recombinant FcepsilonRI gamma-chain immune receptors: an extracellular spacer domain impairs antigen-dependent T cell activation but not antigen recognition. , 2000, Gene therapy.

[6]  A. Rothman,et al.  Bystander Target Cell Lysis and Cytokine Production by Dengue Virus-Specific Human CD4+ Cytotoxic T-Lymphocyte Clones , 1999, Journal of Virology.

[7]  V. Diehl,et al.  A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEA , 1998, Gene Therapy.

[8]  A. Hasegawa,et al.  Simplex Virus-Infected Cells CTL Directed Against Herpes + Human CD 4 Fas-Independent Cytotoxicity Mediated , 1999 .

[9]  T. Ley,et al.  How do cytotoxic lymphocytes kill their targets? , 1998, Current opinion in immunology.

[10]  M. Weijtens,et al.  A retroviral vector system ‘STITCH’ in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes , 1998, Gene Therapy.

[11]  U. Reinhold,et al.  Can combined T-cell- and antibody-based immunotherapy outsmart tumor cells? , 1998, Immunology today.

[12]  T. Ley,et al.  Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation. , 1997, The Journal of clinical investigation.

[13]  C. von Kalle,et al.  Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells. , 1996, Blood.

[14]  S. Rosenberg,et al.  In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes. , 1995, Cancer research.

[15]  R. Ueda,et al.  Immune function in mice lacking the perforin gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[16]  B. Groner,et al.  Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  N. Jenkins,et al.  Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand , 1994, Cell.

[18]  V. Diehl,et al.  CD30‐specific AB1‐AB2‐AB3 internal image antibody network: Potential use as anti‐idiotype vaccine against Hodgkin's lymphoma , 1993, International journal of cancer.

[19]  Z. Eshhar,et al.  Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[20]  W. Dippold,et al.  Humanized anti-carcinoembryonic antigen antibody: strategies to enhance human tumor cell killing. , 1993, The Year in immunology.

[21]  N. Copeland,et al.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis , 1992, Nature.

[22]  J. Kirkwood,et al.  Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells. , 1992, Journal of immunological methods.

[23]  V. Diehl,et al.  Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice. , 1990, Cancer research.